Consumer Health Digest #12-12

Your Weekly Update of News and Reviews
April 5, 2012

Consumer Health Digest is a free weekly e-mail newsletter edited by Stephen Barrett, M.D., with help from William M. London, Ed.D., M.P.H. It summarizes scientific reports; legislative developments; enforcement actions; news reports; Web site evaluations; recommended and nonrecommended books; and other information relevant to consumer protection and consumer decision-making.

Medical groups identifying unnecessary tests. The American Board of Internal Medicine Foundation is spearheading a campaign to educate physicians and the general public about unnecessary medical tests. Nine major medical organizations have contributed fact sheets so far, and eight more are expected to do so in the near future. [Rabin RC. Doctor panels recommend fewer tests for patients. New York Times, April 4, 2012] Each group will spotlight five tests. The first lists are posted on the Choosing Wisely Web site.

Montana chelationist has license suspended. The Montana Board of Medical Examiners has suspended the license of Tommatthew T. Thomas, M.D. for failure to cooperate with an investigation of his use of chelation to treat heart disease. Records from the Board state:

In 2009, the Montana Board concluded that "chelation therapy has no proven efficacy in the treatment of cardiovascular disease, and in some patients could be injurious." [EDTA chelation for cardiovascular disease. Position paper, May 14, 2009] Quackwatch has additional information about chelation therapy.

British chelationist facing charges. The British Medical Council has begun hearings to determine whether Dr. Jean Anne Monro improperly recommended chelation therapy for a patient. Monro is accused of using an inappropriate test to diagnose lead poisoning, failing to inform the patient's general practitioner about possible complications of chelation therapy, and administering it after learning that the GP had reported her to the Council. The British Medical Journal has reported that Monro has admitted sending normal and provoked urine specimens to a laboratory in the United States and failing to measure the patient's blood lead concentration. [Dyer C. Controversial allergy doctor admits faults in her treatment of a patient with lead poisoning. BMJ, March 26, 2012] Provoked urine testing is not a proper way to determine lead toxicity. The hearings are expected to last about two more weeks.

Previous Issue || Next Issue

This page was revised on Apri 18, 2012.